The European Society for Medical Oncology (ESMO) posted on LinkedIn:
“Latest podcast Annals of Oncology Editor-in-Chief Tom Powles talks to Giorgio Bogani. They discuss the recently published study considering recent phase III trials that investigated the role of Immunotherapy in the first-line setting for advanced or recurrent Endometrical Cancer.”
Read further.
Source: The European Society for Medical Oncology (ESMO)/LinkedIn